Methoxamine
Not to be confused with methoxetamine.
|  | |
| Systematic (IUPAC) name | |
|---|---|
| 2-amino-1-(2,5-dimethoxyphenyl)propan-1-ol | |
| Clinical data | |
| AHFS/Drugs.com | International Drug Names | 
| Routes of administration | Intravenous, intramuscular, oral. | 
| Pharmacokinetic data | |
| Bioavailability | 21% (oral), 93% (I.M). | 
| Biological half-life | 18.6 hours | 
| Excretion | renal | 
| Identifiers | |
| CAS Number | 390-28-3  | 
| ATC code | C01CA10 (WHO) | 
| PubChem | CID 6082 | 
| IUPHAR/BPS | 483 | 
| DrugBank | DB00723  | 
| ChemSpider | 5857  | 
| UNII | HUQ1KC1YLI  | 
| KEGG | D08201  | 
| ChEMBL | CHEMBL524  | 
| Chemical data | |
| Formula | C11H17NO3 | 
| Molar mass | 211.258 | 
| 
 | |
| 
 | |
|   (what is this?)  (verify) | |
Methoxamine is an α1-adrenergic receptor agonist,[1] similar in structure to phenylephrine and 2,5-DMA. It was developed by Burroughs-Wellcome in the 1940s.[2] The drug induces vasoconstriction of skin and splanchnic blood vessels, thereby increasing peripheral vascular resistance and raising mean arterial blood pressure. Because of its hypertensive effects, it may evoke a compensatory reflex bradycardia via the baroreceptors.
See also
References
| 
 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 
 | ||||||||||||||||||||||||||||||||||||||||||
| 
 | ||||||||||||||||||||||||
| 
 | ||||||||||||||||||||||||||||||||||
This article is issued from Wikipedia - version of the Monday, April 04, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.